TrialDiabetologia2005

Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.

G Boner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.